跳至主要内容
临床试验/NCT03153267
NCT03153267已完成不适用

Duration of Doxycycline Treatment in Patients With Erythema Migrans (EM). A Randomized Clinical Trial.

University Medical Centre Ljubljana1 个研究点 分布在 1 个国家目标入组 300 人开始时间: 2017年6月1日最近更新:
适应症
干预措施
相关药物

试验速览

阶段
不适用
状态
已完成
入组人数
300
试验地点
1
主要终点
Treatment outcome in patients treated for erythema migrans with doxycycline for 7 or 14 days

研究概览

简要总结

The purpose of this study is to compare the efficacy of 7-day versus 14-day doxycycline treatment in patients with erythema migrans.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
None

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • solitary erythema migrans

排除标准

  • pregnancy or lactation
  • immunocompromised
  • serious adverse event to doxycycline
  • taking antibiotic with antiborrelial activity within 10 days
  • multiple erythema migrans or extracutaneous manifestations of lyme borreliosis

研究组 & 干预措施

EM-7 days doxycycline

Active Comparator

干预措施: Doxycycline 100 MG Oral Tablet bid, 7 days (Drug)

EM-14 days doxycycline

Active Comparator

干预措施: Doxycycline 100 MG Oral Tablet bid, 14 days (Drug)

Controls

Placebo Comparator

干预措施: Controls without a history of lyme disease. (Drug)

结局指标

主要结局

Treatment outcome in patients treated for erythema migrans with doxycycline for 7 or 14 days

时间窗: At 12 months after enrollment.

Objective sequelae and post-treatment subjective new or increased symptoms (NOIS) in patients treated for erythema migrans with doxycycline for 7 or 14 days.

次要结局

  • Comparison of nonspecific symptoms in patients with erythema migrans and control subjects(At 12 months after enrollment.)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Daša Stupica

MD, PhD

University Medical Centre Ljubljana

研究点 (1)

Loading locations...

相似试验

Duration of Doxycycline Treatment in EM Patients | 临床试验